Skip to main content
. 2019 Nov 12;9:1212. doi: 10.3389/fonc.2019.01212

Figure 6.

Figure 6

Validation of stromal-immune score-based risk stratification model in two independent cohorts. (A) Kaplan-Meier plots of overall survival for patients from GEO Series GSE84437, grouped by expression of four signature genes, SOX9, LRRC32, CECR1, and MS4A4A. (B) Correlation between risk scores and living months for patients from GEO Series GSE84437. (C) Kaplan-Meier plot of overall survival according to risk group for patients from GEO Series GSE84437. (D) Kaplan-Meier plots of overall survival for patients from GEO Series GSE62254 grouped by expression of four signature genes, SOX9, LRRC32, CECR1, and MS4A4A. (E) Correlation between risk score and living months for patients from GEO Series GSE62254. (F) Kaplan-Meier plot of overall survival according to risk group for patients from GEO Series GSE62254.